Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma

• Sarfraz Ahmed,
• Aarfa Queen,
• Iram Irfan,
• Mohammad Naseem Siddiqui,
• Haider Thaer Abdulhameed Almuqdadi,
• Nisha Setia,
• Jaoud Ansari,
• Afzal Hussain,
• Md. Imtaiyaz Hassan,
• Mohammad Abid

Affiliations

Sarfraz Ahmed

Department of Biosciences, Medicinal Chemistry Laboratory, Jamia Nagar, New Delhi, India

Aarfa Queen

Centre for Interdisciplinary Research in Basic Sciences, Jamia Nagar, New Delhi, India

Iram Irfan

Department of Biosciences, Medicinal Chemistry Laboratory, Jamia Nagar, New Delhi, India

Mohammad Naseem Siddiqui

Department of Orthopaedics, Indira Gandhi Medical College & Hospital, Shimla, Himachal Pradesh, India

Haider Thaer Abdulhameed Almuqdadi

Department of Biosciences, Medicinal Chemistry Laboratory, Jamia Nagar, New Delhi, India

Nisha Setia

Department of Biosciences, Medicinal Chemistry Laboratory, Jamia Nagar, New Delhi, India

Jaoud Ansari

Centre for Interdisciplinary Research in Basic Sciences, Jamia Nagar, New Delhi, India

Afzal Hussain

Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Md. Imtaiyaz Hassan

Centre for Interdisciplinary Research in Basic Sciences, Jamia Nagar, New Delhi, India

Mohammad Abid

Department of Biosciences, Medicinal Chemistry Laboratory, Jamia Nagar, New Delhi, India